These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10742819)

  • 41. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease.
    De Taeye B; Smith LH; Vaughan DE
    Curr Opin Pharmacol; 2005 Apr; 5(2):149-54. PubMed ID: 15780823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):663-84, ix. PubMed ID: 18775358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent developments in cardiovascular disease in diabetes mellitus.
    Bandyopadhyay P
    Drug News Perspect; 2005 Sep; 18(7):463-75. PubMed ID: 16362086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism).
    Steinberger J; Daniels SR; ;
    Circulation; 2003 Mar; 107(10):1448-53. PubMed ID: 12642369
    [No Abstract]   [Full Text] [Related]  

  • 46. [Obesity. Epidemiology and risks of obesity].
    Gross P; Werhya G; Seng G; Debry G; Drouin P
    Rev Prat; 1989 Nov; 39(26):2355-60. PubMed ID: 2688053
    [No Abstract]   [Full Text] [Related]  

  • 47. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T; Abbasi F; Lamendola C; Reaven G
    Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa.
    Longo-Mbenza B; Ngoma DV; Nahimana D; Mayuku DM; Fuele SM; Ekwanzala F; Beya C
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):503-8. PubMed ID: 18830083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Keeping the diabetic heart healthy.
    Harris M; Wan Q
    Aust Fam Physician; 2005 Jun; 34(6):441-5. PubMed ID: 15931402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 51. Obesity: much silence makes a mighty noise.
    Ahima RS
    Gastroenterology; 2007 May; 132(6):2085-6. PubMed ID: 17498504
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation and prevention of type II diabetes mellitus and cardiovascular diseases in obese children and adolescents: a public health intervention in a local health organisation in Rome (Italy)].
    Doro Altan AM; Manca Bitti ML; Buonomo E; Scarcella P; Mancinelli S; Arcano S; Palombi L
    Ig Sanita Pubbl; 2008; 64(3):345-60. PubMed ID: 18936798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial health effects of modest weight loss.
    Goldstein DJ
    Int J Obes Relat Metab Disord; 1992 Jun; 16(6):397-415. PubMed ID: 1322866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis.
    DeFronzo RA
    Neth J Med; 1997 May; 50(5):191-7. PubMed ID: 9175399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Environmental toxins, obesity, and diabetes: an emerging risk factor.
    Hyman MA
    Altern Ther Health Med; 2010; 16(2):56-8. PubMed ID: 20232619
    [No Abstract]   [Full Text] [Related]  

  • 56. Obesity, diabetes and cardiovascular disease: is the fat lady singing?
    Grant PJ
    Diab Vasc Dis Res; 2006 May; 3(1):5-6. PubMed ID: 16784174
    [No Abstract]   [Full Text] [Related]  

  • 57. Obesity and its complications.
    Okinda NA
    East Afr Med J; 2010 Aug; 87(8):321-2. PubMed ID: 23451553
    [No Abstract]   [Full Text] [Related]  

  • 58. Renal, cardiovascular and metabolic effects of fetal programming.
    Koleganova N; Benz K; Piecha G; Ritz E; Amann K
    Nephrol Dial Transplant; 2012 Aug; 27(8):3003-7. PubMed ID: 22851622
    [No Abstract]   [Full Text] [Related]  

  • 59. [Global differences in causes and diagnostics of cardio-metabolic diseases].
    Christensen DL; Bygbjerg IC; Meyrowitsch DW
    Ugeskr Laeger; 2017 May; 179(20):. PubMed ID: 28504630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy.
    Fagan TC; Sowers J
    Arch Intern Med; 1999 May; 159(10):1033-4. PubMed ID: 10335678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.